Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura E Kilpatrick

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|March 21, 2023
Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine ReceptorSebastian Dekkers, Birgit Caspar, Joëlle Goulding, et al.
RSC Advances|May 11, 2022
Synthesis of novel (benzimidazolyl)isoquinolinols and evaluation as adenosine A1 receptor toolsSameek Singh, Samantha L Cooper, Jacqueline R Glenn, et al.
Communications Biology|April 5, 2024
Mechano-sensitivity of β2-adrenoceptors enhances constitutive activation of cAMP generation that is inhibited by inverse agonistsSean A Cullum, Simon Platt, Natasha Dale, et al.
Science Signaling|March 19, 2024
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycansCarl W White, Simon Platt, Laura E Kilpatrick, et al.
ACS Medicinal Chemistry Letters|January 17, 2024
Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3)Sebastian Dekkers, Dehan Comez, Noemi Karsai, et al.
Journal of Medicinal Chemistry|July 12, 2024
Ligand-Directed Labeling of the Adenosine A<sub>1</sub> Receptor in Living CellsEleonora Comeo, Joëlle Goulding, Chia-Yang Lin, et al.
Biochemical Pharmacology|April 11, 2017
Real-time analysis of the binding of fluorescent VEGF<sub>165</sub>a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexesLaura E Kilpatrick, Rachel Friedman-Ohana, Diana C Alcobia, et al.
Cell Reports Methods|April 14, 2023
NanoB<sup>2</sup> to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRETJelle van den Bor, Nick D Bergkamp, Stephanie M Anbuhl, et al.
Cell Chemical Biology|April 9, 2019
Complex Formation between VEGFR2 and the β<sub>2</sub>-AdrenoceptorLaura E Kilpatrick, Diana C Alcobia, Carl W White, et al.
Oncogene|May 11, 2026
Cannabinoid CB<sub>2</sub> receptor drives trastuzumab resistance and predicts durable anti-HER2 responseMarta Seijo-Vila, Sofía A Balsinde, Sandra Blasco-Benito, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|March 21, 2023
Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine ReceptorSebastian Dekkers, Birgit Caspar, Joëlle Goulding, et al.
RSC Advances|May 11, 2022
Synthesis of novel (benzimidazolyl)isoquinolinols and evaluation as adenosine A1 receptor toolsSameek Singh, Samantha L Cooper, Jacqueline R Glenn, et al.
Communications Biology|April 5, 2024
Mechano-sensitivity of β2-adrenoceptors enhances constitutive activation of cAMP generation that is inhibited by inverse agonistsSean A Cullum, Simon Platt, Natasha Dale, et al.
Science Signaling|March 19, 2024
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycansCarl W White, Simon Platt, Laura E Kilpatrick, et al.
ACS Medicinal Chemistry Letters|January 17, 2024
Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3)Sebastian Dekkers, Dehan Comez, Noemi Karsai, et al.
Journal of Medicinal Chemistry|July 12, 2024
Ligand-Directed Labeling of the Adenosine A<sub>1</sub> Receptor in Living CellsEleonora Comeo, Joëlle Goulding, Chia-Yang Lin, et al.
Biochemical Pharmacology|April 11, 2017
Real-time analysis of the binding of fluorescent VEGF<sub>165</sub>a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexesLaura E Kilpatrick, Rachel Friedman-Ohana, Diana C Alcobia, et al.
Cell Reports Methods|April 14, 2023
NanoB<sup>2</sup> to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRETJelle van den Bor, Nick D Bergkamp, Stephanie M Anbuhl, et al.
Cell Chemical Biology|April 9, 2019
Complex Formation between VEGFR2 and the β<sub>2</sub>-AdrenoceptorLaura E Kilpatrick, Diana C Alcobia, Carl W White, et al.
Oncogene|May 11, 2026
Cannabinoid CB<sub>2</sub> receptor drives trastuzumab resistance and predicts durable anti-HER2 responseMarta Seijo-Vila, Sofía A Balsinde, Sandra Blasco-Benito, et al.
Pageof 5